Literature DB >> 6733709

Phase II study of continuous 5-day vinblastine infusion in renal adenocarcinoma.

J P Kuebler, T F Hogan, D L Trump, G T Bryan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6733709

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.

Authors:  P J Elson; L K Kvols; S E Vogl; D J Glover; R G Hahn; D L Trump; P P Carbone; J D Earle; T E Davis
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

Review 3.  Immunologics and chemotherapeutics for renal cell carcinoma.

Authors:  Elan Diamond; Jamie Riches; Bishoy Faltas; Scott T Tagawa; David M Nanus
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.